EMCDDA Home
  • EN
Search

Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (v) New hypnotics and sedatives outpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium0277167112878078
Bulgaria00000000000
Czech Republic00001122606
Denmark03101030623023
Germany11229344835542004132415
Estonia:::::::::::
Ireland12282310967691091
Greece0171830424024
Spain104781627675601785791580
France131024161114351140114
Italy2008082433571309139
Cyprus02012011707
Latvia313042031023023
Lithuania0002041411011
Luxembourg:::::::::::
Hungary02214231226026
Malta:::::::::::
Netherlands11973514740421193920392
Austria1456322225025
Poland400121111707
Portugal50020243112012
Romania00000000000
Slovenia00001001202
Slovakia0020310410010
Finland0161111112012
Sweden104201244102478078
United Kingdom68100201213208190157458153511536
Croatia0514032520020
Turkey:::::::::::
Norway:::::::::::
Total1523648843646041740711593618133631
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013